Literature DB >> 8503669

Nasal IgA response in wheezy infants.

I M Balfour-Lynn1, B Valman, M Silverman, A D Webster.   

Abstract

It is unknown why some infants wheeze during upper respiratory tract infections. One possibility is that secretory IgA, which has a major role in mucosal defence against viral infection, might be deficient in wheezy infants. The nasal IgA response to upper respiratory tract infection in 32 wheezy infants (median age 5.8 months) was compared with nine siblings (median age 2.6 years) who had nasal symptoms only. Nasal lavage was performed during infections and on follow up when free from symptoms, using inulin as a marker of dilution to determine absolute concentrations of IgA in the nasal secretions. The two groups showed a similar increase in total IgA and total protein levels during infection, but secretory IgA concentrations were unchanged. This study shows that wheezy infants have a normal nasal IgA response to infection and that the increase in total IgA during early infection is due to plasma exudation rather than increased production of secretory IgA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503669      PMCID: PMC1029267          DOI: 10.1136/adc.68.4.472

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  35 in total

1.  A new method for the determination of inulin in plasma and urine.

Authors:  A HEYROVSKY
Journal:  Clin Chim Acta       Date:  1956 Sep-Oct       Impact factor: 3.786

2.  Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man.

Authors:  W T Butler; T A Waldmann; R D Rossen; R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-09       Impact factor: 5.422

3.  The mechanism of appearance of immunoglobulin A in nasal secretions in man.

Authors:  W T Butler; R D Rossen; T A Waldmann
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

4.  Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.

Authors:  R H Alford; R D Rossen; W T Butler; J A Kasel
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

5.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

6.  Protein composition of nasal secretion during respiratory virus infection.

Authors:  R D Rossen; W T Butler; T R Cate; C F Szwed; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

7.  Immunoglobulins in nasal secretions of infants.

Authors:  A B Cohen; S Goldberg; R L London
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

8.  A comparison of the immunoglobulins IgA, IgG and IgE in nasal secretions from normal and asthmatic children.

Authors:  J D Hobday; M Cake; K J Turner
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

9.  Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions.

Authors:  R Scott; P S Gardner
Journal:  J Hyg (Lond)       Date:  1970-12

10.  The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children.

Authors:  K McIntosh; E F Ellis; L S Hoffman; T G Lybass; J J Eller; V A Fulginiti
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

View more
  5 in total

Review 1.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

Review 2.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

3.  Analysis of lower airway inflammation in a rabbit model of acute rhinosinusitis.

Authors:  Adin Selcuk; Ozgur Akdogan; Seren Gulsen Giray; Kursat Murat Ozcan; Ibrahim Ozcan; Huseyin Dere; Serdar Ensari; Candan Ozogul
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-11

Review 4.  Early humoral defence: Contributing to confining COVID-19 to conducting airways?

Authors:  Carl Persson
Journal:  Scand J Immunol       Date:  2021-02-07       Impact factor: 3.889

5.  An adult model of exclusive viral wheeze: inflammation in the upper and lower respiratory tracts.

Authors:  M C Mckean; C Hewitt; P C Lambert; St Myint; M Silverman
Journal:  Clin Exp Allergy       Date:  2003-07       Impact factor: 5.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.